Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01977495 · ClinicalTrials.gov registry record · NA

Take Charge of Your Diabetes

A NA study of Hypertension and Diabetes, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
136
Enrollment target
1
Study location

NCT01977495: Completed NA study of Hypertension and Diabetes, sponsored by University of Pennsylvania.

NCT01977495 is a NA study of Hypertension and Diabetes that has completed, run by University of Pennsylvania. The registered enrollment target is 136 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01977495, a NA study of Hypertension and Diabetes, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
136 participants
Enrollment target
1
Study location

Study Summary

The investigator plans to assess enrollment rates among two different enrollment methods, while providing a behavioral economic intervention to enhance the uptake of home-health monitoring devices to lower hemoglobin A1C among patients with uncontrolled diabetes. The study is focusing on enrollment methods since the standard randomized control trial only reaches 15% of the population. The study is seeking to understand the effectiveness of a behavioral intervention, when rolled out in a larger population.

Primary Outcome

The primary objective is to obtain preliminary evidence regarding whether or not patients opt-into a research study, as opposed to enrolling by default, will affect participation in the program and the effectiveness of the intervention, among high-risk patients. The primary outcome is to measure enrollment rates. The investigators will also measure participation in the program through device usage.

Conditions Studied

Interventions

  • BEHAVIORAL Financial Incentive: Fixed Lottery

Study Locations (1)

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 136 participants
Start Date 2013-12
Est. Completion 2014-08
Phase NA
University of Pennsylvania

1,423 total trials

What the finished NCT01977495 record still lists

NCT01977495 is an interventional study that assigns participants to a tested intervention. The registered 136 participants enrollment target is mid-sized for trials with a published cap, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (96% lower).

The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Financial Incentive: Fixed Lottery is the first listed.

NCT01977495 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT01977495 about?

NCT01977495 is a clinical study titled "Take Charge of Your Diabetes". The investigator plans to assess enrollment rates among two different enrollment methods, while providing a behavioral economic intervention to enhance the uptake of home-health monitoring devices to lower hemoglobin A1C among patients with uncontrolled diabetes. The study is focusing on enrollment ...

What is the current status of trial NCT01977495?

This trial is currently completed. It is a NA study. The enrollment target is 136 participants. The study started on 2013-12. Estimated completion is 2014-08.

What conditions does trial NCT01977495 study?

This clinical trial studies the following conditions: Hypertension, Diabetes.

What interventions are being tested in trial NCT01977495?

The interventions under investigation include: Financial Incentive: Fixed Lottery (BEHAVIORAL).

Who is sponsoring clinical trial NCT01977495?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01977495 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01977495's enrollment target sits among peer trials

136 261st of 470 higher than 210 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01555892 · 136 participants · Phase 1

    Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE

  • NCT03216525 · 136 participants · Phase 3

    Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol

  • NCT04476901 · 136 participants · Phase 2

    Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy

  • NCT04603898 · 136 participants · NA

    Oxalate Formation From Ascorbic Acid

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01977495, the US trial registry maintained by the National Library of Medicine. NCT01977495 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.